Clinical Trial

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
Closed due to slow enrollment.
Summary
Chronic limb-threatening ischemia (CLTI) is a serious condition that happens when blood flow to the legs or feet is severely reduced. This can lead to constant pain, wounds that don't heal, infections, and in some cases, the need for amputation. Some people with CLTI have such severe artery disease that doctors are unable to restore blood flow using standard treatments like surgery or stents. For these patients, major amputation may be the only remaining option. This study aims to test a new surgical technique called transverse tibial bone transport, which has been shown in some previous small studies to help improve blood flow and promote healing of wounds in the legs and feet. These early studies suggest that the procedure may help wounds heal better and reduce the need for amputation in people with severe circulation problems. This research will help us learn more about how safe and effective this technique is for patients who have no other treatment options other than amputation.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Withdrawn 2026-05-30
critical Reason stopped changed: — → Closed due to slow enrollment. 2026-05-30
notable Enrollment reduced: 10 -> 0 participants 2026-05-30
Trial Details
NCT Number NCT07175129
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions Chronic Limb Threatening Ischemia
Start Date 2026-01-05
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-29